Amedco Provided the CE Credit for this activity. We can do the same for you. Click Here.
ARS 68th Annual Meeting (2022)

Select your name from the dropdown list

Your role(s) in this event


Welcome...

Thank you for agreeing to participate on the creation and delivery of ARS 68th Annual Meeting (2022)

What you need to know

Before you can begin your role in this activity, we need to ask you some questions, give you some instructions, and have you agree to several statements.

When you finish, the system will immediately let you know if there is anything else you need to do, or if we need to follow up with you.

Everyone involved in the creation and delivery of this activity must complete this site in order to participate. It will only take a couple minutes to finish, so start clicking.

Definition of Financial Relationship...

Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria for promotional speakers’ bureau, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. Contracted research includes research funding where the institution gets the grant and manages the fund's and the person is the principal or named investigator on the grant. There is no minimum dollar amount for relationships.

Definition of Ineligible Company...

An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Providers of clinical service directly to patients are not ineligible companies (unless the provider of clinical service is owned, or controlled by, an ineligible company)

In the past 24 months, have you had a financial relationship with any ineligible company?

Details of the financial relationship(s).

If you have a lot to disclose, group them by relationship. Like this!

Statement 1

I will not accept payments or reimbursements from an ineligible company (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.) for my role in the planning and delivery of this CME activity. If I am approached by an ineligible company in this regard, I will immediately notify American Rhinologic Society.

Statement 2

Continuing medical education consists of educational activities which serve to maintain, develop, or increase the knowledge, skills, and professional performance and relationships that a physician uses to provide services for patients, the public, or the profession. The content of CME is that body of knowledge and skills generally recognized and accepted by the profession as within the basic medical sciences, the discipline of clinical medicine, and the provision of health care to the public. If I am a presenter, my presentation will meet these standards, and if I’m a planner, I will not approve any content that does not meet these standards. If I am a session chair and/or an abstract discussant, any contribution I make to discussion, will meet these standards.

Statement 3

Presentations that promote recommendations, treatment, or manners of practicing medicine that are not within the definition of CME, or known to have risks or dangers that outweigh the benefits or known to be ineffective in the treatment of patients are prohibited. Presentations devoted to advocacy of unscientific modalities of diagnosis or therapy are prohibited. If I am a presenter, my presentation will meet these standards, and if I’m a planner, I will not approve any content that does not meet these standards. If I am a session chair and/or an abstract discussant, any contribution I make to discussion, will meet these standards.

Statement 4

All recommendations involving clinical medicine in a CME activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection and analysis. If I am a presenter, my presentation will meet these standards, and if I’m a planner, I will not approve any content that does not meet these standards. If I am a session chair and/or an abstract discussant, any contribution I make to discussion, will meet these standards.

Statement 5

Presentations must give a balanced view of therapeutic options. Use of generic names will contribute to this impartiality. If the CME educational material or content includes trade names, where available trade names from several companies should be used, not just trade names from a single company. If I am a presenter, my presentation will meet this standard, and if I’m a planner, I will not approve any content that does not meet this standard. If I am a session chair and/or an abstract discussant, any contribution I make to discussion, will meet this standard.

Statement 6

Educational materials that are a part of this activity, such as slides, abstracts, and handouts, cannot contain any advertising, trade names, or product-group messages, or ineligible company logos. If I am a presenter, my presentation will meet this standard, and if I’m a planner, I will not approve any content that does not meet this standard. If I am a session chair and/or an abstract discussant, any contribution I make to discussion, will meet this standard.

Statement 7

The content or format of a CME activity or its related materials must promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. If I am a presenter, my presentation will meet this standard, and if I’m a planner, I will not approve any content that does not meet this standard. If I am a session chair and/or an abstract discussant, any contribution I make to discussion, will meet this standard.

Statement 8

The content of the CME activity must not be influenced by any ineligible company. If I am a presenter, my presentation will meet this standard, and if I'm a planner, I will not approve any content that does not meet this standard.

Statement 9

If I participate in a non-faculty role, such as planner or reviewer, I will recuse myself from planning educational content related to my financial relationships, or alternatively, my educational content decisions will be reviewed by a planner who has no conflict of interest and who has sufficient expertise to plan this activity.

Statement 10

If I am an abstract reviewer, I will not score any abstracts of which I am an author or which I know to be from my institution. If I have a financial relationship with a company engaged in producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients and whose products or services are the subject of an abstract I am reviewing, I will refrain from scoring that abstract. Additionally, I will base my recommendations for content selection solely on the mean score when I have a financial relationship with a company engaged in producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients and whose products or services are the subject of an abstract I am selecting.

Good News!

That's all we need... You're Done!

Success

There's nothing else you need to do.

Here's what you told us for a past activity...

No relationships with relevant ineligible companies in the past 24 months.

Is there anything that needs to be added, edited, or removed?

Yes, I need to make a few CHANGES
Nothing needs to be updated. This is CORRECT AS IS